{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T21:30:43Z","timestamp":1784064643287,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dry eye disease (DED) is common in Rheumatoid Arthritis (RA) patients. The application of conjunctival goblet cell count as a clinical biomarker to diagnose and respond to treatment can take place in rheumatoid arthritis patients under TNF-inhibitors (TNFi) therapy. This study aimed to investigate the ocular surface parameters and the long-term effects of TNFi therapy on ocular surface features and goblet cell count of rheumatoid arthritis patients. At baseline, rheumatoid arthritis patients eligible to TNFi were compared to healthy controls (similar age\/gender), regarding Ocular Surface Disease Index (OSDI) questionnaire, Schirmer I test, tear break-up time test, vital dye staining of the ocular surface, and conjunctival impression cytology. DED severity grade, impression cytology score, and goblet cell count were analyzed. Rheumatoid arthritis patients were followed after three (3\u00a0M) and 12\u00a0months (12\u00a0M), during TNFi treatment. Sixteen rheumatoid arthritis patients and 24 controls were compared: a higher frequency of abnormal OSDI (68.8% vs. 16.7%, <jats:italic>p<\/jats:italic>\u2009=\u20090.002), Schirmer\u2019s test\u2009&lt;\u200910\u00a0mm (37.5% vs. 8.3%, <jats:italic>p<\/jats:italic>\u2009=\u20090.042), meibomian gland dysfunction (50% vs. 8.3%, <jats:italic>p<\/jats:italic>\u2009=\u20090.007), abnormal impression cytology (75% vs. 8.3%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and mild to moderate DED (81.3% vs. 4.2%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) were observed in rheumatoid arthritis patients, who also had lower goblet cell count [325 (274\u2013707) cells\/mm<jats:sup>2<\/jats:sup> vs. 742 (562\u2013863) cells\/mm<jats:sup>2<\/jats:sup>, <jats:italic>p<\/jats:italic>\u2009=\u20090.004]. The presence of Meibomian gland dysfunction was associated with higher disease activity scores (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). The prospective early observation of these patients at 3\u00a0M showed an increase improvement in tear production by Schirmer\u2019s test [13 (7.5\u201317.5) vs. 23.5 (16\u201335); <jats:italic>p<\/jats:italic>\u2009=\u20090.001], and an improvement in impression cytology score [1 (0.5\u20132) vs. 1 (0\u20131), <jats:italic>p<\/jats:italic>\u2009=\u20090.031] and in goblet cell count [325 (274\u2013707) vs. 931 (656\u20131,244), <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001]. Eight RA responders to TNFi were also re-evaluated at 12\u00a0M with further improvement in goblet cell count [393 (275\u2013827) vs. 872 (502\u20131,185) vs. 1,079 (867\u20131,244), <jats:italic>p<\/jats:italic>\u2009=\u20090.047]. Multifactorial DED is frequent in RA patients, comprising aqueous, lipid, and mucin components. TNFi prompt improves tear production and recovers the goblet cells, which can be a biomarker of the pathological process and response to therapy in this population.<\/jats:p>","DOI":"10.1038\/s41598-020-70944-9","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T10:07:20Z","timestamp":1597918040000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Dry eye in rheumatoid arthritis patients under TNF-inhibitors: conjunctival goblet cell as an early ocular biomarker"],"prefix":"10.1038","volume":"10","author":[{"given":"Fany Solange","family":"Usuba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cristina","family":"de Medeiros-Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila","family":"Novaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia Emi","family":"Aikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Bonfiglioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth Miyuki","family":"Santo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloisa","family":"Bonf\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton Ruiz","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,20]]},"reference":[{"key":"70944_CR1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3899\/jrheum.101133","volume":"38","author":"E Myasoedova","year":"2011","unstructured":"Myasoedova, E., Crowson, C. S., Turesson, C., Gabriel, S. E. & Matteson, E. L. Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in 1995\u20132007 versus 1985\u20131994 a population-based study. J. Rheumatol. 38, 983\u2013989 (2011).","journal-title":"J. Rheumatol."},{"key":"70944_CR2","doi-asserted-by":"crossref","unstructured":"Smolen J.S., Aletaha D &McInnes I.B. Rheumatoid Arthritis. Lancet. 388, 2023\u201338 (2016).","DOI":"10.1016\/S0140-6736(16)30173-8"},{"key":"70944_CR3","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ajo.2005.05.025","volume":"140","author":"M Fujita","year":"2005","unstructured":"Fujita, M. et al. Correlation between dry eye and rheumatoid arthritis activity. Am. J. Ophthalmol. 140, 808\u2013813 (2005).","journal-title":"Am. J. Ophthalmol."},{"key":"70944_CR4","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","volume":"15","author":"F Stapleton","year":"2017","unstructured":"Stapleton, F. et al. TFOS DEWS II epidemiology report. Ocul. Surf. 15, 334\u2013365 (2017).","journal-title":"Ocul. Surf."},{"key":"70944_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004397-199803810-00003","volume":"38","author":"SL Harper","year":"1998","unstructured":"Harper, S. L. & Foster, C. S. The ocular manifestations of rheumatoid disease. Int. Ophthalmol. Clin. 38, 1\u20139 (1998).","journal-title":"Int. Ophthalmol. Clin."},{"key":"70944_CR6","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0161-6420(03)00462-7","volume":"110","author":"RM Schiffman","year":"2003","unstructured":"Schiffman, R. M. et al. Utility assessment among patients with dry eye disease. Ophthalmology 110, 1412\u20131419 (2003).","journal-title":"Ophthalmology"},{"key":"70944_CR7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1542-0124(12)70043-5","volume":"4","author":"P Buchholz","year":"2006","unstructured":"Buchholz, P. et al. Utility assessment to measure the impact of dry eye. Ocul. Surf. 4, 155\u2013161 (2006).","journal-title":"Ocul. Surf."},{"key":"70944_CR8","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","volume":"15","author":"AJ Bron","year":"2017","unstructured":"Bron, A. J. et al. TFOS DEWS II pathophysiology report. Ocul. Surf. 15, 438\u2013510 (2017).","journal-title":"Ocul. Surf."},{"key":"70944_CR9","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.1167\/iovs.10-7022","volume":"52","author":"JE Moore","year":"2011","unstructured":"Moore, J. E. et al. Effect of tear hyperosmolarity and signs of clinical ocular surface pathology upon conjunctival goblet cell function in the human ocular surface. Invest. Ophthalmol. Vis. Sci. 52, 6174\u20136180 (2011).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"70944_CR10","first-page":"7757","volume":"54","author":"YW Ji","year":"2013","unstructured":"Ji, Y. W. et al. Neutralization of ocular surface TNF-\u03b1 reduces ocular surface and lacrimal gland inflammation induced by in vivo dry eye. Invest. Ophthalmol. Vis. Sci. 54, 7757\u20137766 (2013).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"70944_CR11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/09273940701299354","volume":"15","author":"M Cordero-Coma","year":"2007","unstructured":"Cordero-Coma, M., Anzaar, F., Sobrin, L. & Foster, C. S. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation. Ocul. Immunol. Inflamm. 15, 99\u2013104 (2007).","journal-title":"Ocul. Immunol. Inflamm."},{"key":"70944_CR12","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha, D. et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthrit. Rheum. 62, 2569\u20132581 (2010).","journal-title":"Arthrit. Rheum."},{"key":"70944_CR13","first-page":"962","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen, J. S. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann. Rheum. Dis. 69, 962\u2013975 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"70944_CR14","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali, C. et al. Classifications criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 61, 554\u2013558 (2002).","journal-title":"Ann. Rheum. Dis."},{"key":"70944_CR15","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jclinepi.2014.07.009","volume":"68","author":"RM Santo","year":"2015","unstructured":"Santo, R. M., Ribeiro-Ferreira, F., Alves, M. R., Epstein, J. & Novaes, P. Enhancing the cross-cultural adaptation and validation process: linguistic and psychometric testing of the Brazilian\u2013Portuguese version of a self-report measure for dry eye. J. Clin. Epidemiol. 68, 370\u2013378 (2015).","journal-title":"J. Clin. Epidemiol."},{"key":"70944_CR16","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","volume":"118","author":"RM Schiffman","year":"2000","unstructured":"Schiffman, R. M., Christianson, M. D., Jacobsen, G., Hirsch, J. D. & Reis, B. L. Reliability and validity of the Ocular Surface Disease Index. Arch. Ophthalmol. 118, 615\u2013621 (2000).","journal-title":"Arch. Ophthalmol."},{"key":"70944_CR17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/ICO.0000000000000038","volume":"33","author":"JR Grubbs","year":"2014","unstructured":"Grubbs, J. R., Tolleson-Rinehart, S., Huynh, K. & Davis, R. M. A review of quality of life measures in dry eye questionnaires. Cornea 33, 215\u2013218 (2014).","journal-title":"Cornea"},{"key":"70944_CR18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/OPTH.S80043","volume":"10","author":"KA Beckman","year":"2015","unstructured":"Beckman, K. A., Luchs, J. & Milner, M. S. Making the diagnosis of Sj\u00f6gren\u2019s syndrome in patients with dry eye. Clin. Ophthalmol. 10, 43\u201353 (2015).","journal-title":"Clin. Ophthalmol."},{"key":"70944_CR19","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ophtha.2017.05.031","volume":"124","author":"P Chhadva","year":"2017","unstructured":"Chhadva, P., Goldhardt, R. & Galor, A. Meibomian gland disease: the role of gland dysfunction in dry eye disease. Ophthalmology 124, S20\u2013S26 (2017).","journal-title":"Ophthalmology"},{"key":"70944_CR20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1001\/archopht.1969.00990020012003","volume":"82","author":"OP van Bijsterveld","year":"1969","unstructured":"van Bijsterveld, O. P. Diagnostic tests in Sicca syndrome. Arch. Ophthalmol. 82, 10\u201314 (1969).","journal-title":"Arch. Ophthalmol."},{"key":"70944_CR21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ajo.2009.09.013","volume":"149","author":"JP Witcher","year":"2010","unstructured":"Witcher, J. P. et al. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sj\u00f6gren\u2019s Syndrome International Registry. Am. J. Ophthalmol. 149, 405\u2013415 (2010).","journal-title":"Am. J. Ophthalmol."},{"key":"70944_CR22","doi-asserted-by":"crossref","unstructured":"Research in dry eye: report of the Research Subcommittee of the International Dry Eye WorkShop (DEWS). The definition and classification of dry eye disease. Ocul. Surf. 5, 75\u201392 (2007).","DOI":"10.1016\/S1542-0124(12)70081-2"},{"key":"70944_CR23","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jtos.2014.02.002","volume":"12","author":"AJ Bron","year":"2014","unstructured":"Bron, A. J. et al. Rethinking dry eye disease: a perspective on clinical implications. Ocul. Surf. 12, S1\u2013S31 (2014).","journal-title":"Ocul. Surf."},{"key":"70944_CR24","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1167\/iovs.06-0817","volume":"48","author":"MJ Gonz\u00e1lez-Garcia","year":"2007","unstructured":"Gonz\u00e1lez-Garcia, M. J. et al. Exposure at a controlled adverse environment impairs the ocular surface of subjects with minimally symptomatic dry eye. Invest. Ophthalmol. Vis. Sci. 48, 4026\u20134032 (2007).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"70944_CR25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00003226-198801000-00012","volume":"7","author":"JD Nelson","year":"1988","unstructured":"Nelson, J. D. Impression cytology. Cornea 7, 71\u201381 (1988).","journal-title":"Cornea"},{"key":"70944_CR26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.exer.2015.04.007","volume":"136","author":"MJ Doughty","year":"2015","unstructured":"Doughty, M. J. A systematic assessment of goblet cell sampling of the bulbar conjunctiva by impression cytology. Exp. Eye Res. 136, 16\u201328 (2015).","journal-title":"Exp. Eye Res."},{"key":"70944_CR27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.envres.2014.02.014","volume":"131","author":"AA Torricelli","year":"2014","unstructured":"Torricelli, A. A. et al. Effects of ambient levels of traffic-derived air pollution on the ocular surface: analysis of symptoms, conjunctival goblet cell count and mucin 5AC gene expression. Environ. Res. 131, 59\u201363 (2014).","journal-title":"Environ. Res."},{"key":"70944_CR28","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/ICL.0b013e3182480eb1","volume":"38","author":"MJ Doughty","year":"2012","unstructured":"Doughty, M. J. Sampling area selection for the assessment of goblet cell density from conjunctival impression cytology specimens. Eye Contact Lens. 38, 122\u2013129 (2012).","journal-title":"Eye Contact Lens."},{"key":"70944_CR29","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/acr.21649","volume":"64","author":"J Anderson","year":"2012","unstructured":"Anderson, J. et al. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthrit. Care Res. (Hoboken). 64, 640\u2013647 (2012).","journal-title":"Arthrit. Care Res. (Hoboken)."},{"key":"70944_CR30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jtos.2013.02.002","volume":"11","author":"M Alves","year":"2013","unstructured":"Alves, M. et al. Dry eye disease treatment: a systematic review of published trials and a critical appraisal of therapeutic strategies. Ocul. Surf. 11, 181\u2013192 (2013).","journal-title":"Ocul. Surf."},{"key":"70944_CR31","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/bjophthalmol-2013-304619","volume":"98","author":"C Baudoin","year":"2014","unstructured":"Baudoin, C. et al. Diagnosing the severity of dry eye: a clear and practical algorithm. Br. J. Ophthalmol. 98, 1168\u20131176 (2014).","journal-title":"Br. J. Ophthalmol."},{"key":"70944_CR32","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.rdc.2016.03.010","volume":"42","author":"FB Vivino","year":"2016","unstructured":"Vivino, F. B. et al. New treatment guidelines for Sj\u00f6gren\u2019s disease. Rheum. Dis. Clin. North Am. 42, 531\u2013551 (2016).","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"70944_CR33","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jtos.2016.09.005","volume":"15","author":"SV Aluru","year":"2017","unstructured":"Aluru, S. V. et al. Tear fluid protein changes in dry eye syndrome associated with rheumatoid arthritis: a proteomic approach. Ocul. Surf. 15, 112\u2013129 (2017).","journal-title":"Ocul. Surf."},{"key":"70944_CR34","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1167\/tvst.7.5.26","volume":"7","author":"S Karakus","year":"2018","unstructured":"Karakus, S., Akpek, E. K., Agrawal, D. & Massof, R. W. Validation of an objective marker of dry eye severity. Trans. Vis. Sci. Tech. 7, 26. https:\/\/doi.org\/10.1167\/tvst.7.5.26 (2018).","journal-title":"Trans. Vis. Sci. Tech."},{"key":"70944_CR35","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/bjophthalmol-2015-307415","volume":"100","author":"C Baudoin","year":"2016","unstructured":"Baudoin, C. et al. Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction. Br. J. Ophthalmol. 100, 300\u2013306 (2016).","journal-title":"Br. J. Ophthalmol."},{"key":"70944_CR36","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","volume":"15","author":"JS Wolffsohn","year":"2017","unstructured":"Wolffsohn, J. S. et al. TFOS DEWS II diagnostic methodology report. Ocul. Surf. 15, 539\u2013574 (2017).","journal-title":"Ocul. Surf."},{"key":"70944_CR37","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11095-019-2569-8","volume":"36","author":"M Tamhane","year":"2019","unstructured":"Tamhane, M., Cabrera-Ghayouri, S., Abelian, G. & Viswanath, V. Review of biomarkers in ocular matrices: challenges and opportunities. Pharm. Res. 36, 40. https:\/\/doi.org\/10.1007\/s11095-019-2569-8 (2019).","journal-title":"Pharm. Res."},{"key":"70944_CR38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jtos.2019.11.005","volume":"18","author":"SK Swamynathan","year":"2020","unstructured":"Swamynathan, S. K. & Wells, A. Conjunctival goblet cells: ocular surface functions, disorders that affect them, and the potential for their regeneration. Ocul. Surf. 18, 19\u201326 (2020).","journal-title":"Ocul. Surf."},{"key":"70944_CR39","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.molmed.2015.06.003","volume":"21","author":"HA McCauley","year":"2015","unstructured":"McCauley, H. A. & Guasch, G. Three cheers for the goblet cell: maintaining homeostasis in mucosal epithelia. Trends Mol. Med. 21, 492\u2013503 (2015).","journal-title":"Trends Mol. Med."},{"key":"70944_CR40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0161-6420(97)30330-3","volume":"104","author":"SC Pflugfelder","year":"1997","unstructured":"Pflugfelder, S. C. et al. Correlation of goblet cell density and mucosal epithelial membrane mucin expression with rose Bengal staining in patients with ocular irritation. Ophthalmology 104, 223\u2013235 (1997).","journal-title":"Ophthalmology"},{"key":"70944_CR41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.preteyeres.2014.10.001","volume":"44","author":"AJ Bron","year":"2015","unstructured":"Bron, A. J., Arg\u00fceso, P., Irvek, M. & Bright, F. V. Clinical staining of the ocular surface: mechanisms and interpretations. Prog. Retin. Eye Res. 44, 36\u201361 (2015).","journal-title":"Prog. Retin. Eye Res."},{"key":"70944_CR42","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1475-1313.2009.00683.x","volume":"29","author":"MJ Doughty","year":"2009","unstructured":"Doughty, M. J. & Glavin, S. Efficacy of different dry eye treatments with artificial tears or ocular lubricants: a systematic review. Ophthal. Physiol. Opt. 29, 573\u2013583 (2009).","journal-title":"Ophthal. Physiol. Opt."},{"key":"70944_CR43","doi-asserted-by":"crossref","first-page":"636812","DOI":"10.1155\/2013\/636812","volume":"2013","author":"L Contreras-Ruiz","year":"2013","unstructured":"Contreras-Ruiz, L., Ghosh-Mitra, A., Shatos, M. A., Dartt, D. A. & Masli, S. Modulation of conjunctival goblet cell function by inflammatory cytokines. Mediators Inflamm. 2013, 636812 (2013).","journal-title":"Mediators Inflamm."},{"key":"70944_CR44","doi-asserted-by":"crossref","first-page":"7545","DOI":"10.1167\/iovs.15-17627","volume":"56","author":"SC Pflugfelder","year":"2015","unstructured":"Pflugfelder, S. C. et al. Aqueous tear deficiency increases conjunctival Interferon-\u0263 (IFN-\u0263) and goblet cell loss. Invest. Ophthalmol. Vis. Sci. 56, 7545\u20137550 (2015).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"70944_CR45","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/ICO.0b013e31803dcda2","volume":"26","author":"KC Yoon","year":"2007","unstructured":"Yoon, K. C., Jeong, I. N., Park, Y. G. & Yang, S. Y. Interleukin-6 and tumor necrosis factor-\u03b1 levels in tears of patients with dry eye syndrome. Cornea 26, 431\u2013437 (2007).","journal-title":"Cornea"},{"key":"70944_CR46","first-page":"224","volume":"9","author":"RK Mallya","year":"1982","unstructured":"Mallya, R. K. et al. Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate. J. Rheumatol. 9, 224\u2013228 (1982).","journal-title":"J. Rheumatol."},{"key":"70944_CR47","first-page":"1227","volume":"21","author":"F Wolfe","year":"1994","unstructured":"Wolfe, F. & Michaud, K. The clinical and research significance of the erythrocyte sedimentation rate. J. Rheumatol. 21, 1227\u20131237 (1994).","journal-title":"J. Rheumatol."},{"key":"70944_CR48","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nrrheum.2014.85","volume":"10","author":"L Tong","year":"2014","unstructured":"Tong, L., Thumboo, J., Tan, Y. K., Wong, T. Y. & Albani, S. The eye: a window of opportunity in rheumatoid arthritis?. Nat. Rev. Rheumatol. 10, 552\u2013560 (2014).","journal-title":"Nat. Rev. Rheumatol."},{"key":"70944_CR49","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/ICO.0b013e318158f6dc","volume":"27","author":"SC Pflugfelder","year":"2008","unstructured":"Pflugfelder, S. C., De Paiva, C. S., Villareal, A. L. & Stern, M. E. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-\u03b22 production. Cornea 27, 64\u201369 (2008).","journal-title":"Cornea"},{"key":"70944_CR50","first-page":"135","volume":"160","author":"QL Moore","year":"2015","unstructured":"Moore, Q. L., De Paiva, C. S. & Pflugfelder, S. C. Effects of dry eye therapies on environmentally induced ocular surface disease. J. Ophthalmol. 160, 135\u2013142 (2015).","journal-title":"J. Ophthalmol."},{"key":"70944_CR51","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/aos.12012","volume":"92","author":"BD Sullivan","year":"2014","unstructured":"Sullivan, B. D. et al. Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications. Acta Ophthalmol. 92, 161\u2013166 (2014).","journal-title":"Acta Ophthalmol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70944-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70944-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70944-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T17:14:15Z","timestamp":1670346855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70944-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,20]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["70944"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-70944-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,20]]},"assertion":[{"value":"23 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14054"}}